Showing results (91-100 of 365) with videos related to
Sort By:
Pageof 37
Circulation|July 13, 2000
Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trialC P Cannon, C H McCabe, R G Wilcox, et al.Journal of the American College of Cardiology|August 1, 1990
Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. The Thrombolysis in Myocardial Infarction (TIMI) Phase II Co-InvestigatorsL D Hillis, S Forman, E BraunwaldLancet (London, England)|November 14, 2001
Acute coronary syndrome without ST elevation: implementation of new guidelinesC W Hamm, M Bertrand, E BraunwaldThe American Journal of Cardiology|June 1, 1975
Effects of hypoxemia on the extent of myocardial necrosis after experimental coronary occlusionP Radvany, P R Maroko, E BraunwaldAnnals of Internal Medicine|September 12, 1998
The antiplatelet effects of ticlopidine and clopidogrelP J Sharis, C P Cannon, J LoscalzoThe New England Journal of Medicine|June 23, 2001
Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofibanC P Cannon, W S Weintraub, L A Demopoulos, et al.Circulation|January 21, 1997
TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trialC P Cannon, C H McCabe, C M Gibson, et al.Annals of Internal Medicine|September 1, 1980
Increased plasma norepinephrine levels during prazosin therapy for severe congestive heart failureW S Colucci, G H Williams, E BraunwaldThe Journal of Clinical Investigation|July 1, 1981
Early recovery of regional performance in salvaged ischemic myocardium following coronary artery occlusion in the dogJ R Darsee, R A Kloner, E BraunwaldAnnals of Internal Medicine|December 1, 1981
Efforts to limit the size of myocardial infarctsR E Rude, J E Muller, E BraunwaldPageof 37